Our quality product service solutions bridge the gaps between technology and patient care by providing custom-tailored cell therapy services, including:
- Contract Manufacturing
- Product & Process Development
- Consulting
- GTP Services
- National Distribution
Library
(select publications)
Abstract Title: Cryopreservation of Hematopoietic Progenitor Cells (HPC) Apheresis using 5% Dimethyl Sulfoxide without Hydroxyethyl Starch. Authors: Wai Shun Chan, Andrew L. Pecora, Suzi Nadasi, Lester Myers, Margarita Munoz, Besa Jashari and Robert A. Preti. August 2006.
F. Fong, Progenitor Tackles Obstacles in Cell Therapy, Genetic Engineering News, Vol. 25, No. 17. 1 October 2005.
Preti R, Bringing safe and effective cell therapies to the bedside, Nature Biotechnology, Vol. 23, No. 7. July 2005.
Hami LS, Green C, Leshinsky N, Markham E, Miller K, Craig S, GMP production of Xcellerated T Cells for the treatment of patients with CLL, Cytotherapy (2004), Vol. 6, No. 6, 554-562.
Hami L, Chana H, Yuan V, Craig S, Comparison of a Static Process and a Bioreactor-based Process for the GMP Manufacture of Autologous Xcellerated T Cells for Clinical Trials, BioProcessing Journal, Vol. 2, No. 6. Nov/Dec 2003.
